Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 52 views
- Toyota Suspends Production at 2 Plants in Japan Citing Chip Shortage 52 views
- Expect Even More Unique Electric Cars Says Ferrari 44 views
- Kimberly Goldwin Poised to Become Next President of ABC News 31 views
- Records Show 19,000 U.S Based Amazon Employees Contracted Coronavirus 27 views